The Foundation for the Accreditation of Cellular Therapy (FACT) has announced the formation of a ‘Community CAR T Working Group’ (working group) to discuss and propose clinical accreditation standards for community-based providers of CAR T cell therapies. ¹⁵¹

The working group builds on discussions around the multiple, complex challenges surrounding eligible patient access to these innovative therapies. Comprised primarily of community-based physicians currently administering—or preparing to administer—CAR T-cell therapies, the working group also includes leaders from academic medical centers, representatives of relevant professional societies and members of FACT headquarters.¹⁵⁰

This effort will operate in association with the development of the upcoming third edition of the FACT Standards for Immune Effector Cells, scheduled for release later this year,¹⁵⁰ with the expected output being to guide physicians toward the development and maintenance of quality- and safety-focused infrastructure and systems, closer to the homes and workplaces of eligible patients.¹⁵⁰